Non-Opioid EXPAREL Shows Health, Economic Benefits
Pooled data show that EXPAREL® (bupivacaine liposome injectable suspension) slashes opioid consumption, risk of opioid- related side effects, length of postsurgery hospital stay, and cost.
Pooled data show that EXPAREL® (bupivacaine liposome injectable suspension) slashes opioid consumption, risk of opioid- related side effects, length of postsurgery hospital stay, and cost.
Study results presented at EADV 2025 show nearly half of initial complete responders maintained clearance over four years.